Varaico: Literature-Extracted Genetic Variants

Gene:CDC42
Variant:p.R186C
Back to variants list

CDC42

NM_001791.4:p.R186C

Associated Papers

Interpreting the functional impact of genetic variants: The need for context qualifiers.

Martinelli S et al.

American Journal of Human Genetics, 2026

Dysregulation of inflammasomes in autoinflammatory diseases.

Hou C et al.

Joint Bone Spine, 2025

CDC42 missense mutations and human diseases: from neurodevelopmental disorders to autoinflammation.

Yasumi T

Journal of Biochemistry, 2025

Conserved missense variant pathogenicity and correlated phenotypes across paralogous genes.

Brünger T et al.

Genome Biology, 2025

40624578 (PubMed )
Supplement: 13059_2025_3663_MOESM2_ESM.xlsx › SupplementaryTable1

Clinical and laboratory aspects of patients diagnosed with various inherited platelet disorders.

Gök V et al.

Research and Practice in Thrombosis and Haemostasis, 2025

Current landscape of monogenic autoinflammatory actinopathies: A literature review.

Mertz P et al.

Autoimmunity Reviews, 2025

Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation and ER stress.

Iannuzzo A et al.

Nature Communications, 2024

Human induced pluripotent stem cells (NIHTVBi029-A and NIHTVBi030-A) generated from two patients with a heterozygous mutation in the CDC42 gene.

Varea I et al.

Stem Cell Research, 2024

Genetics of Primary Hemophagocytic Lymphohistiocytosis.

Karageorgos S et al.

Advances in Experimental Medicine and Biology, 2024

A Novel CDC42 Variant with Impaired Thymopoiesis, IL-7R Signaling, PAK1 Binding, and TCR Repertoire Diversity.

Assing K et al.

Journal of Clinical Immunology, 2023

[Monogenic auto-inflammatory diseases associated with actinopathies: A review of the literature].

Mertz P et al.

La Revue De Medecine Interne, 2023

C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinib.

Kapp FG et al.

Clinical Immunology (orlando, Fla.), 2023

Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature.

Ręka G et al.

Cells, 2023

A CDC42 Stop-loss Mutation in a Patient with Relapsing Polychondritis and Autoinflammation.

van Wijck RTA et al.

Journal of Clinical Immunology, 2023

36040659 (PubMed )
Supplement: 10875_2022_1344_MOESM1_ESM.xlsx › Sheet1

The hyperinflammatory spectrum: from defects in cytotoxicity to cytokine control.

Planas R et al.

Frontiers in Immunology, 2023

The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.

La Bella S et al.

Frontiers in Immunology, 2023

CDC42 regulates PYRIN inflammasome assembly.

Spel L et al.

Cell Reports, 2022

Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders.

Coppola S et al.

The Journal of Allergy and Clinical Immunology, 2022

Hematopoietic stem cell transplantation in systemic autoinflammatory diseases - the first one hundred transplanted patients.

Signa S et al.

Expert Review of Clinical Immunology, 2022

Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation.

Nishitani-Isa M et al.

The Journal of Experimental Medicine, 2022

Immune-mediated inflammatory diseases with chronic excess of serum interleukin-18.

Miyazawa H et al.

Frontiers in Immunology, 2022

Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases.

Shimizu M et al.

Frontiers in Immunology, 2022

Selectivity Determinants of RHO GTPase Binding to IQGAPs.

Mosaddeghzadeh N et al.

International Journal of Molecular Sciences, 2021

Infection and autoinflammation in inborn errors of immunity: brothers in arms.

Delafontaine S et al.

Current Opinion in Immunology, 2021

RHO GTPases: from new partners to complex immune syndromes.

El Masri R et al.

Nature Reviews. Immunology, 2021

Small Rho GTPases and their associated RhoGEFs mutations promote immunological defects in primary immunodeficiencies.

Hashim IF et al.

The International Journal of Biochemistry & Cell Biology, 2021

Aplasia cutis congenita in a CDC42-related developmental phenotype.

Schnabel F et al.

American Journal of Medical Genetics. Part A, 2021

Pancytopenia, Recurrent Infection, Poor Wound Healing, Heterotopia of the Brain Probably Associated with A Candidate Novel de Novo CDC42 Gene Defect: Expanding the Molecular and Phenotypic Spectrum.

Asiri A et al.

Genes, 2021

Inborn errors of immunity with atopic phenotypes: A practical guide for allergists.

Castagnoli R et al.

The World Allergy Organization Journal, 2021

Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.

Politiek FA et al.

Frontiers in Immunology, 2021

[An abnormal palmitoylation arising from a mutation of CDC42 results in a severe autoinflammatory syndrome].

El Masri R et al.

Medecine Sciences : M/s, 2020

Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys Mutation.

Bucciol G et al.

Journal of Clinical Immunology, 2020

1–50 of 58 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."